These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9316629)

  • 21. Will new treatment strategies improve the control of non-Hodgkin's lymphomas?
    Bonadonna G
    Curr Opin Oncol; 1994 Sep; 6(5):453-5. PubMed ID: 7827146
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epirubicin-based combination chemotherapy combined with G-CSF for the elderly patients with non-Hodgkin's lymphoma].
    Miyata A; Fujii S; Kikuchi T; Kibata M
    Nihon Ronen Igakkai Zasshi; 2000 Feb; 37(2):155-61. PubMed ID: 10793559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
    Bregni M; Siena S; Magni M; Bonadonna G; Gianni AM
    Leukemia; 1991; 5 Suppl 1():123-7. PubMed ID: 1716335
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in chemotherapy for Hodgkin's and non-Hodgkin's lymphomas.
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):1-73. PubMed ID: 3399906
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epirubicin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma: with emphasis of elderly patients].
    Sampi K; Takouda K; Hattori M
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1925-8. PubMed ID: 2393310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
    Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk models for chemotherapy-induced neutropenia in non-Hodgkin's lymphoma.
    Zelenetz AD
    Oncology (Williston Park); 2003 Nov; 17(11 Suppl 11):21-6. PubMed ID: 14682115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyoderma gangrenosum in a syringe driver site of a patient with non-Hodgkin's lymphoma.
    Curtis C; Douglas I
    Palliat Med; 2006 Mar; 20(2):113-4. PubMed ID: 16615193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients].
    Izumi T; Muroi K; Hoshino Y; Komatsu N; Ohtsuki T; Yamada M; Tomizuka H; Hatake K; Furusawa S; Miura Y
    Gan To Kagaku Ryoho; 1996 May; 23(6):797-800. PubMed ID: 8645033
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid infusion rituximab changing practice for patient care.
    Al Zahrani A; Ibrahim N; Al Eid A
    J Oncol Pharm Pract; 2009 Sep; 15(3):183-6. PubMed ID: 19171551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].
    Li HH; Wu XX; Wang QS; Zhao Y; Bo J; Wang SH; DA WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):298-300. PubMed ID: 16638201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MECHOP-BM chemotherapy in the treatment of non Hodgkin's lymphoma].
    Inoue N; Miyazaki E; Okada M; Wada H; Nishimura T; Tamura S; Fujimori Y; Okamoto T; Takemoto Y; Kosaki M
    Rinsho Ketsueki; 1994 Jun; 35(6):535-40. PubMed ID: 8078187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
    Shim BY; Lee MA; Byun JH; Roh SY; Song CW; Park JN; Lee JW; Min WS; Hong YS; Kim CC
    Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolism. A complication of weekly chemotherapy in the treatment of non-Hodgkin's lymphoma.
    Clarke CS; Otridge BW; Carney DN
    Cancer; 1990 Nov; 66(9):2027-30. PubMed ID: 2224801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for large cell lymphoma: a status update.
    Yi PI; Coleman M; Saltz L; Norton L; Topilow AA; Adler K; Bernhardt B
    Semin Oncol; 1990 Feb; 17(1):60-73. PubMed ID: 2406919
    [No Abstract]   [Full Text] [Related]  

  • 37. Brief weekly chemotherapy for elderly patients with intermediate-grade or high-grade non-Hodgkin's lymphoma.
    Inanç SE; Onat H
    J Natl Cancer Inst; 1993 Jul; 85(13):1088-9. PubMed ID: 8515496
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
    J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
    Basaran G; Basaran M; Onat H
    J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.